1. |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
DOI
URL
|
2. |
SMITH R A, FEDEWA S, SIEGEL R. Early colorectal cancer detection-current and evolving challenges in evidence,guidelines,policy,and practices[J]. Adv Cancer Res, 2021, 151:69-107.
|
3. |
VAN DOORN R, VAN HORSSEN J, VERZIJL D, et al. Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions[J]. Glia, 2010, 58(12):1465-1476.
DOI
PMID
|
4. |
SÁNCHEZ D I, GONZÁLEZ-FERNÁNDEZ B, SAN-MIGUEL B, et al. Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma[J]. J Pineal Res, 2017, 62(1).
|
5. |
SHIDA D, INOUE S, YOSHIDA Y, et al. Sphingosine kinase 1 is upregulated with lysophosphatidic acid receptor 2 in human colorectal cancer[J]. World J Gastroenterol, 2016, 22(8):2503-2511.
DOI
URL
|
6. |
SATTAR R S A, SUMI M P, NIMISHA, et al. S1P signaling,its interactions and cross-talks with other partners and therapeutic importance in colorectal cancer[J]. Cell Signal, 2021, 86:110080.
DOI
URL
|
7. |
BENAMOUZIG R, BARRÉ S, SAURIN J C, et al. Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals[J]. Therap Adv Gastroenterol, 2021, 14:17562848211002359.
|
8. |
IMPERIALE T F, RANSDOHOFF D F, ITZKOWITZ S H, et al. Multitarget stool DNA testing for colorectal-cancer screening[J]. N Engl J Med, 2014, 370(14):1287-1297.
DOI
URL
|
9. |
陈思, 刘华, 刘鷖雯, 等. 血清HER-2、CD44联合检测在结直肠癌中的临床价值[J]. 检验医学, 2022, 37(4):336-341.
|
10. |
AHLQUIST D A, TAYLOR W R, MAHONEY D W, et al. The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia[J]. Clin Gastroenterol Hepatol, 2012, 10(3):272-277. e1.
DOI
URL
|
11. |
SHAUKAT A, LEVIN T R. Current and future colorectal cancer screening strategies[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(8):521-531.
DOI
PMID
|
12. |
SUKOCHEVA O A, FURUYA H, NG M L, et al. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers:a novel therapeutic target[J]. Pharmacol Ther, 2020, 207:107464.
DOI
URL
|
13. |
ANDRIEU G, LEDOUX A, BRANKA S, et al. Sphingosine 1-phosphate signaling through its receptor S1P5 promotes chromosome segregation and mitotic progression[J]. Sci Signal, 2017, 10(472):eaah4007.
DOI
URL
|
14. |
PYNE N J, PYNE S. Recent advances in the role of sphingosine 1-phosphate in cancer[J]. FEBS Lett, 2020, 594(22):3583-3601.
DOI
URL
|
15. |
GU X, JIANG Y, XUE W, et al. SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway[J]. Clin Exp Pharmacol Physiol, 2019, 46(9):861-871.
DOI
URL
|
16. |
YAN J, CHEN Y, WU Q, et al. Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells:a preliminary clinical study[J]. Oncol Lett, 2022, 24(1):241.
DOI
URL
|
17. |
NUNES J, NAYMARK M, SAUER L, et al. Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection[J]. Br J Cancer, 2012, 106(5):909-915.
DOI
|